Infectious Disease Billing — Built for Your Practice
Infectious disease bills almost entirely on cognitive work, not procedures — which means there's no procedure revenue to fall back on when an E&M visit gets coded conservatively. Reviewing multiple culture and susceptibility reports, imaging, and a patient's prior antimicrobial history is exactly the kind of data complexity that should drive a higher-level code, but it routinely gets undercoded because reviewing lab data doesn't "feel" as billable as a procedure.
The other place ID revenue disappears is OPAT — outpatient IV antimicrobial therapy that splits into two completely different billing pathways depending on who's actually administering the drug. Bill infusion administration codes for a course a home infusion pharmacy is running, and you're billing for work your practice didn't do. Our ID billing team levels every E&M visit to actual MDM complexity, routes OPAT through the correct pathway, and captures the HIV chronic care management and telehealth consult revenue most ID practices leave on the table.
What's Costing Infectious Disease Practices Money Right Now
These are the specific, avoidable spots where infectious disease revenue quietly disappears before a claim ever gets appealed.
E&M visits involving multiple culture and susceptibility reports get coded at a routine level instead of the higher complexity the data review actually supports — and there's no procedure revenue to offset the loss.
Infusion administration codes get billed for an OPAT course a home infusion pharmacy is actually administering, creating a claim for work the practice never performed.
Inpatient consult codes billed to Medicare after the 2010 elimination trigger an automatic denial on every affected claim.
HIV and chronic infection patients who qualify for Chronic Care Management go unbilled because the practice doesn't think of ID as a chronic-care specialty.
Telehealth ID consultations get billed with the wrong place-of-service code or modifier, denying a service that was performed correctly.
Antimicrobial stewardship and prolonged data-review work goes undocumented, leaving MDM-supported higher E&M levels uncaptured.
Top Infectious Disease Claim Denial Reasons — and How We Eliminate Them
Most Infectious Disease denials are preventable. Our team knows exactly what to look for before submission.
❌ Infusion Administration Billed for a Home Infusion Course the Physician Didn't Administer
A patient is discharged on a multi-week IV antibiotic course managed by a home infusion pharmacy — the pharmacy's nursing staff administers the drug and bills its own per-diem/nursing-visit codes. If the ID practice also bills infusion administration codes (96365/96366) for the same treatment course because the physician wrote the orders and is following the patient, that's billing for a service the practice didn't actually perform — the physician's billable work is the E&M visit and oversight, not the infusion administration.
✓ Our Fix
We determine which entity is physically administering the OPAT drug — home infusion agency vs. the practice's own infusion suite or a hospital outpatient department — before assigning infusion administration codes, and bill the physician's side only for the E&M and oversight work actually performed.
❌ Inpatient Consult Codes Billed to Medicare After 2010 Elimination
Medicare eliminated formal consultation codes (99251–99255, 99241–99245) in 2010, requiring physicians — including ID consultants — to bill initial hospital care (99221–99223) or subsequent hospital care (99231–99233) codes instead, with modifier AI on the principal physician of record's claim. ID practices that still default to consult codes across all payers get automatic denials on every Medicare claim.
✓ Our Fix
We bill initial/subsequent hospital care codes for all Medicare inpatient encounters and reserve true consultation codes only for the specific commercial payers that still recognize and pay them.
❌ E&M Level Undercoded Relative to Actual Data Complexity Reviewed
An ID encounter involving review of multiple culture and susceptibility reports, imaging, and prior antimicrobial history from outside records meets the data-complexity criteria for a higher E&M level, but gets coded at a moderate level because the visit "felt" like a routine follow-up rather than a complex one. Since ID has essentially no procedure revenue to offset this, systematic undercoding compounds across the entire practice's revenue rather than being absorbed by procedure billing the way it might be in a proceduralist specialty.
✓ Our Fix
We review the actual data reviewed and problems addressed against the current MDM E&M framework for every encounter, coding to what the documentation supports rather than a habitual default level.
❌ HIV/Chronic Infection Chronic Care Management Never Billed
Patients on long-term HIV management or chronic infection suppression — exactly the kind of longitudinal, multi-condition population CCM was designed for — routinely qualify for Chronic Care Management billing, but most ID practices never set up a CCM program because they don't think of infectious disease as a "chronic care" specialty the way primary care is.
✓ Our Fix
We identify HIV and chronic infection patients meeting CCM eligibility criteria and implement a CCM billing program with the required care plan, consent, and time-tracking documentation.
Our Infectious Disease Billing Process, Start to Finish
MDM-Based E&M Coding
Every encounter is coded against the current MDM framework's actual data-review and risk criteria — not a habitual default level — since ID revenue is almost entirely E&M-driven.
Eligibility & OPAT Pathway Verification
We determine which entity is physically administering the OPAT drug — home infusion agency vs. the practice's own infusion suite — before assigning infusion administration codes.
Compliance & Consult Code Audits
Medicare inpatient encounters are billed under initial/subsequent hospital care codes, never the eliminated consult codes, while commercial payers that still recognize true consult codes are billed accordingly.
Denial Prevention & Recovery
HIV and chronic infection patients are checked against CCM eligibility criteria, and any denial that still occurs is tracked, corrected at the root, and appealed.
Reporting & Revenue Insights
A real-time dashboard shows your collection rate, E&M level distribution, and outstanding claims, so you always know where your ID revenue stands.
Everything Included with ZenoMedix RCM Infectious Disease Billing
- OPAT billed through the correct pathway — home infusion agency vs. practice/hospital infusion center
- Inpatient consult billing correctly split between Medicare hospital-care codes and commercial consult codes
- E&M level selection matched to actual data complexity reviewed, not a habitual default level
- HIV management and monitoring billing including viral load and CD4 interpretation capture
- CCM billing program for HIV and chronic infection patients
- Telehealth ID consultation billing with correct POS codes and modifiers
- Antimicrobial stewardship documentation support
- 95%+ collection rate for infectious disease practices
Complete Revenue Cycle for Infectious Disease Practices
What Sets ZenoMedix RCM Apart in Infectious Disease Billing
Not every billing company is built the same way. Here's what changes when your infectious disease claims run through ours.
MDM-Trained Coders for a Cognitive-Work Specialty
We map each encounter's actual data reviewed and problems addressed to the current MDM framework — since ID has no procedure revenue to offset a habitually undercoded visit.
Every Denial Appealed, Never Written Off
A Medicare consult-code denial or a mis-routed OPAT claim gets tracked, corrected at the root cause, and appealed — never simply absorbed as a loss.
Pay Only When We Collect
Percentage-based pricing tied to what we actually collect for your practice, with no long-term contract locking you in.
Real-Time Visibility Into Your Revenue
A live dashboard shows your collection rate, E&M level distribution, and outstanding claims — no waiting on a monthly PDF.
We Partner With Every Type of Infectious Disease Practice
Inpatient ID Consult Services
Initial and subsequent hospital care billing correctly split between Medicare hospital-care codes and commercial consult codes for hospital-requested ID consultations.
HIV & Chronic Infection Management Practices
CCM billing programs built for HIV and chronic infection patients on long-term suppression therapy, including viral load and CD4 monitoring interpretation.
OPAT / Outpatient Infusion Center Practices
Infusion administration and J-code billing for practices running their own infusion suite, correctly separated from home-infusion-managed OPAT courses.
Antimicrobial Stewardship Programs
E&M level documentation support for the data-complexity work of antimicrobial stewardship review, tied to the actual MDM criteria met.
Tele-ID Consultation Services
Place-of-service coding and modifier application for hospital-requested virtual ID consults, correct for each payer's telehealth billing rules.
Multi-Drug-Resistant Infection Management Practices
High-complexity E&M coding (99215) for MDR infection management, leveled to the actual data-review complexity of resistant-organism treatment planning.
Infectious Disease Billing Available in All 50 States
From California to New York, our Infectious Disease billing specialists understand your state's Medicaid program, payer mix, and compliance requirements.
Find Your State →Infectious Disease Billing FAQ
For Medicare, we use initial hospital care codes (99221–99223) for the first ID encounter and subsequent hospital care codes (99231–99233) for follow-up visits, since CMS eliminated formal consultation codes in 2010 — the requesting/consulting relationship is instead indicated with modifier AI reserved for the principal physician of record, not the consultant. For commercial payers that still recognize and pay true consultation codes (99251–99255), we bill those when the payer's policy supports it. Billing consult codes to Medicare produces an automatic denial, which is a surprisingly common error among practices that don't separate their Medicare and commercial billing logic.
These are two entirely different billing pathways for the same clinical treatment. When a home infusion pharmacy or agency administers the IV antibiotics, their nursing staff bills its own per-diem or nursing-visit codes and the pharmacy bills the drug separately — the ID physician's billable work in that scenario is the E&M visit and ongoing oversight, not an infusion administration code. When the ID practice's own infusion suite, or a hospital outpatient infusion center, administers the drug, standard infusion administration codes (96365 first hour, 96366 each additional hour) plus the drug's J-code are billed on the medical benefit. Billing infusion administration for a course actually managed by an outside home infusion company is one of the most common OPAT billing errors we correct.
Infectious disease has almost no procedure-code revenue to fall back on — nearly all billable work is cognitive: reviewing culture and susceptibility results, imaging, and prior antimicrobial exposure to build a treatment plan. Under the current MDM-based E&M framework, that data review is exactly the kind of complexity that should drive a higher-level code, but it often gets coded conservatively because reviewing lab data doesn't feel as billable as performing a procedure. Because there's no procedure revenue to offset it, systematic E&M undercoding has an outsized effect on an ID practice's total revenue compared to a specialty that bills a mix of E&M and procedures.
HIV management billing includes E&M visits leveled to actual MDM complexity, interpretation of monitoring labs — including HIV-1 quantitative viral load (87536) and CD4 count — and, for patients on ongoing long-term management, Chronic Care Management (99490) eligibility that most ID practices never bill because they don't think of infectious disease as a chronic-care specialty. We identify HIV and chronic infection patients meeting CCM criteria and implement the required care plan, consent, and time-tracking documentation to capture that recurring monthly revenue.
Yes. Tele-ID consultation volume, including hospital-requested virtual consults for hospitalized patients, has grown substantially, and billing it correctly requires the right place-of-service code and modifier combination — which differ from in-person consult billing and vary by payer. We apply the correct telehealth billing rules for each payer and coordinate with hospitals on telehealth consults requested by hospitalist teams.
Infectious Disease Billing Results — By the Numbers
See How Much More Your Infectious Disease Practice Can Collect
- ✓Specialty-specific coding analysis
- ✓Denial pattern review
- ✓Payer mix assessment
- ✓Revenue recovery estimate